Catherine Jacobson - 21 Feb 2023 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
Director
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
21 Feb 2023
Transactions value $
$0
Form type
4
Filing time
23 Feb 2023, 15:08:34 UTC
Previous filing
31 May 2022
Next filing
26 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +734 +23.6% 3,840 21 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -734 -100% $0.000000* 0 21 Feb 2023 Common Stock 734 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F3 On February 21, 2020, the reporting person was granted 2,202 restricted stock units that vest in three substantially equal annual installments.